CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China · Delayed Price · Currency is CNY 23.95
-0.64 (-2.60%)
Jun 18, 2026, 3:07 PM CST
SHE:300765 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHE:300765 stock has a consensus rating of "Strong Buy" and an average price target of ¥49.13. The average 1-year stock price forecast is 105.14% higher than the current stock price, while the lowest is ¥41.00 (+71.19%) and the highest is ¥61.40 (+156.37%).
Price Target: ¥49.13 (+105.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHE:300765 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 4 | 3 |
Financial Forecast
Revenue This Year
4.37B
from 2.16B
Increased by 102.72%
Revenue Next Year
5.27B
from 4.37B
Increased by 20.54%
EPS This Year
0.69
from -0.21
EPS Next Year
0.81
from 0.69
Increased by 17.02%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.2B | ||
| Avg | 4.4B | ||
| Low | 3.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 138.7% | ||
| Avg | 102.7% | ||
| Low | 82.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.69 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |